Industry landscapes
Get Pro
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE GURUGRAM EDITION 2026

Gurugram’s
healthtech industry,
in focus.

The companies, capital and talent shaping healthtech in Gurugram. Find the leaders. Understand the segments. See where the activity is.

Explore in Radar Read the key signals
Snapshot: Funding in USD
Illustrated cover for Healthtech Industry Landscape of Gurugram
IN
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Healthtech illustration
Companies tracked 278Healthtech ecosystem in Gurugram Disclosed funding $773.64M54 companies · all recorded rounds Companies hiring 37With open roles at the snapshot Tracked open roles 10312 employers posted in the preceding 30 days
MEET THE COMPANIES

Explore Gurugram’s healthtech leaders

22 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Explore the full landscape
Healthtech company highlights in Gurugram, snapshot 5 August 2026
Company
Bright LifeCareblife.in$228.99M—1,036Financial figure available in RadarView in Radar
Pristyn Carepristyncare.com$186.71M—934Financial figure available in RadarView in Radar
Healthianshealthians.com$80.89M—1,808$26.91MFYFY2025 filing
THBthb.group$33.38M——$7.82MFYFY2025 filing
Virohanvirohan.com$26.62M6 roles325$3.41MFYFY2025 filing
Aknamedaknamed.com$21.85M—175$6.92MFYFY2025 filing
SS Innovations Internationalssinnovations.com$21.07M—216Financial figure available in RadarView in Radar
HexaHealthhexahealth.com$18.52M5 roles260—
Eli Lilly and Companylillyinsulinedu.com—13 roles——
ConvaTecconvatec.com—7 roles64—
Elektaelekta.com—7 roles4,607—
Sova Healthsova.health—6 roles17—
Lissunlissun.app—5 roles10$537.37KFYFY2025 filing
Tap Healthtap.health—4 roles12—
Care.ficarefi.in——32—
Emohaemoha.com——249$7.12MFYFY2025 filing
Ivoclarivoclar.com——518Financial figure available in RadarView in Radar
MDD Medical Systemsmddmedical.com——375$13.72MFYFY2025 filing
Newminewmi.in——22—
Orikam Healthcare Indiaorikamhealthcare.com——317$12.75MFYFY2025 filing
Zealthixzealthix.com————
Zoplarzoplar.com——19—
22 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Startup discovery

Recorded classifications only
THE KEY SIGNALS

Healthtech industry KPIs in Gurugram

A few useful ratios bring the size of this ecosystem into perspective.

5 August 2026
Hiring participation13.3%

37 of 278 tracked companies have open roles.

Funding participation20.9%

58 of 278 tracked companies have a recorded round.

Top 3 funding share64.2%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$956.94K

Midpoint of 164 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 64.2% of disclosed capital, while 79.1% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How Gurugram healthtech has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

Gurugram healthtech
$0$67.06M$134.13M$201.19M$268.25M2016: $23.99M20162017: $8.04M20172018: $23.52M20182019: $68.01M20192020: $34.88M20202021: $207.52M20212022: $235.31M20222023: $24.69M20232024: $34.74M20242025: $22.08M2025
View the numbers
Annual healthtech funding and company formation in Gurugram
YearFunding (USD)FoundedRaising
2016$23.99M1712
2017$8.04M136
2018$23.52M2213
2019$68.01M2613
2020$34.88M2216
2021$207.52M2718
2022$235.31M1613
2023$24.69M2313
2024$34.74M1517
2025$22.08M89
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • Bright LifeCare29.6%
  • Pristyn Care24.1%
  • Healthians10.5%
  • Other companies35.8%

Funding by stage

182 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel102 56.0%
Series A–B48 26.4%
Series C+ / PE10 5.5%
Grants, debt & other22 12.1%

Recent recorded rounds

Latest recorded rounds · USD
5 rounds

Swipe or scroll horizontally to browse.

Seed05/2026
Nowound $1.91M

Backed by Alkemi Growth Capital and Sanjay Arora and others.

Seed02/2026
Callbaba $6.5M

Backed by General Catalyst and Genius Ventures and others.

Series A02/2026
Care.fi $5M

Backed by July Ventures and Peak XV Partners and others.

Conventional Debt02/2026
Care.fi $3M

Backed by Trifecta Capital and Vivriti Capital.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

Series B11/2022
THBthb.group$20M

Backed by Filter Capital and HealthQuad and others.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.

Expand panel +
₹ crore · standalone

Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.

FY2025 · annual statements grouped by reported fiscal year; exact entity periods remain on preview rows · 96 reporting entities from 118 eligible matches.

Revenue in covered accounts₹6,668.1 crore

Sum of reporting-entity revenue; not Gurugram market sales.

Net profit / loss₹46.8 crore

Combined result for the same cohort.

Aggregate net margin+0.7%

Combined net income ÷ combined revenue.

Median company revenue₹3.0 crore

The middle covered reporting entity.

Profitable entities+37.5%

36 of 96 covered entities.

Top-five concentration+68.4%

Share of covered revenue from the five largest entities.

Annual account trend

Reported cohort totals by year; coverage is stated for every period.

Bar height shows revenue. Changes in coverage can affect totals.

Profitability has two perspectives

FY2025 · 96 reporting entities

Open the company accounts

Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.

96 reporting entities
Continue your financial research in Radar

Explore full company accounts and filings.

View financials in Radar ↗
GURUGRAM · INDUSTRY COHORTS

How does healthtech compare?

Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.

IndustryCovered / eligibleRevenue totalMedian revenueNet profit / lossAggregate marginProfitable shareOverlap

Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.

Coverage, calculations & financial sources

Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.

The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.

Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the Gurugram companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Busiest websites

11 of the 278 companies on this page carry a measured traffic record (4%); these are the largest of those, by monthly visits. The median among them is 386,802 visits.

CompanyMonthly visitsAuthorityMobile
HexaHealthhexahealth.com2,073,8755594.8%
Lybratelybrate.com2,041,0817492.7%
Pristyn Carepristyncare.com1,631,6926891.5%
Zanskar Healthzanskarhealth.in1,559,5201498.8%
Healthianshealthians.com1,456,3565094.6%
Luna Ringlunazone.com386,8023290.4%
MAX Labmaxlab.co.in353,4574078%
ConvaTecconvatec.com213,8074658%
Credihealthcredihealth.com211,9114281.7%
Ivoclarivoclar.com106,6964339.7%

Visits and authority are third-party web estimates, not company-reported figures.

Most-installed apps

52 of these companies (18.7%) publish at least one Android app — 77 apps in all, carrying 11.2M installs between them.

AppInstallsRatingStore category
Healthians -Full Body CheckupHealthians6.5M4.4Medical
Pristyn Care- Healthcare AppPristyn Care1.6M—Medical
Stamurai: Stuttering TherapyStamurai370.1K4.6Health & Fitness
Max Lab - Blood TestMAX Lab310.3K—Medical
Zyla: Your 24x7 health expertZyla307.6K4.9Medical
Hindustan WellnessHindustan Wellness280K—Medical
HexaHealth: Surgery SimplifiedHexaHealth253.2K—Medical
Tap Health: Blood Sugar CoachTap Health181.3K—Health & Fitness
VirohanVirohan178.7K—Education
Emoha - Support for SeniorsEmoha170.1K4Health & Fitness

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q1–2026Q2).

SegmentAppsInstallsLeading appRelease trend
Healthcare Booking Platforms4210.2MHealthians -Full Body Checkup 6.5M
Disease Self Management10817.7KStamurai: Stuttering Therapy 370.1K
Healthcare It22507KZyla: Your 24x7 health expert 307.6K
Employee Health It6341.7KHappiMynd-Emotional Self Help 25.8K
Assistive Tech4330KEmoha - Support for Seniors 170.1K
Hrtech2308.5KHealth Checkup: HbA1c, Lipid, 823
Higher Education Tech4188.1KVirohan 178.7K
Wearable Technology2181.3KSilverWings 157.1K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

Release cadence by quarter

New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.

2022Q4: 12022Q4: 22022Q42023Q1: 12023Q1: 02023Q12023Q2: 12023Q2: 32023Q22023Q3: 12023Q3: 12023Q32023Q4: 12023Q4: 22023Q42024Q2: 32024Q2: 22024Q22024Q3: 22024Q3: 22024Q32025Q1: 12025Q1: 02025Q12025Q2: 22025Q2: 12025Q22025Q3: 12025Q3: 32025Q32026Q1: 12026Q1: 132026Q1

Darker bars are new releases, lighter bars apps updated. 43 of 77 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.

INSIDE THE INDUSTRY

The Gurugram healthtech market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Consumer digital157
Enterprise tech106
Enterprise software39
Saas35
B2c e-commerce34
Healthtech saas30
Life sciences30
Loneliness economy17
Marketplaces16
Femtech12
At home diagnostics11
Digital diagnostics platforms7

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Consumer digital

The largest measured segment in this report snapshot.

157companies
12.7%have hiring activity

20 companies hiring · $646.41M disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Subscription156
E-commerce - product79
Commission on transaction51
Fee-for-service43
Physical commerce42
E-commerce - service36
Advertising17
Lending2
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 9 dated reports
Mergers & acquisitionslillyinsulinedu.com ↗

Pacific Park Financial Inc. acquired a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 900 shares of the company’s stock, valued at approximately $967,000.

Funding roundsssinnovations.com ↗

SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII ), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that on March 6, 2026, the Company completed a private placement of its common stock (the “Private Placement”) which generated approximately $18.6 million in gross proceeds, before deducting offering expenses.

Funding roundscarefi.in ↗

Care.fi landed $8 million to help hospitals in India run better and faster…

Funding roundsvirohan.com ↗

Mynavi Corporation is leading the ongoing Series B funding round for healthcare edtech startup Virohan, which has raised Rs 65 crore ($7.5 million).

Funding roundszealthix.com ↗

Zealthix, a comprehensive SaaS based Healthcare platform has raised USD 1.1 Million in a seed round led by Unicorn India Ventures with participation from AlphaGen Venture Capital.

Mergers & acquisitionslissun.app ↗

The US-based mental wellness startup Being Cares Inc. was purchased by mental health platform LISSUN.

Funding roundspristyncare.com ↗

Pristyn Care, an Indian surgery-focused hospital chain, raised $4 million as part of a larger round to support the expansion of its owned hospitals, enhance patient care delivery, and scale its operational tech stack.

Funding roundshexahealth.com ↗

Other notable early-stage startups that secured funding include HexaHealth, a healthtech platform, and Anveshan, a foodtech company.

Earningselekta.com ↗

Net income was SEK 12 M (336) and basic earnings per share was SEK 0.03 (0.89).

Full recorded event mix

Top 10 categories among 160 recorded events in the 24-month window.

Funding rounds
46
Earnings
36
Leadership moves
27
Mergers & acquisitions
16
Capital infusions
14
Company announcements
7
New products
5
Contracts
4
Job creation
2
Buyback
1
4 activity cards

Swipe or scroll horizontally to browse.

IPO pipeline

1 companies with recorded IPO activity

IPO1 reports

Leadership moves

12 tracked people moves

Healthians ↗
Nishant Singhal

Promotion Chief Executive Officer

Elekta ↗
Karan Mehrotra

Appointment Marketing Director – Turkey, India, Middle East and Africa

Healthians ↗
Deepak Sahni

Resignation Previously Executive Chairman

Emoha ↗
Adesh Singh Chadha

Appointment Head of Sales

Gaurav Bagga

Resignation Previously Chief Product and Technology Officer

Prabhat Agarwal

Resignation Previously Finance Head

Ramnik Kumar

Resignation Previously Vice President of Finance

Elekta ↗
Klara Eiritz

Appointment Chief Financial Officer

Workforce actions

1 companies with reported reductions

120 rolesprofitability

Earnings pulse

Reported company results in the recorded window.

8companies
37period observations
43.0%median reported growth

Median across 33 reported growth observations; companies may contribute multiple periods.

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
pacific park financial→Eli Lilly and Company ↗Announced2026-05-03$967.0K
brighton jones→Eli Lilly and Company ↗Announced2026-05-03$7.4M
revolve wealth partners→Eli Lilly and Company ↗Announced2026-05-03$1.1M
schnieders capital management→Eli Lilly and Company ↗Announced2026-05-03$6.2M
flow traders→Eli Lilly and Company ↗Announced2026-05-03$356.0K
Nebula Research & Development LLC→Eli Lilly and Company ↗Announced2026-05-03$749.0K

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

176 postings in the preceding 12 months. The full 211-posting snapshot covers 31 employers.

Expand panel +

Most advertised job titles

Data Analyst21
Data Analyst, Reimbursement, In Seller Reimbursements5
Clinical Psychologist5
Speech Therapist4
Speech Language Pathologist4
Operations Executive4
0 internship postings

3 tracked postings mention remote work.

The seniority mix

91 postings specify a level.

unspecified
120
manager
48
senior
22
lead
13
intern
5
entry
3

Skills employers mention

Top skills across 211 tracked postings in the available jobs snapshot.

Python
40
Sql
35
Excel
18
Power Bi
17
Aws
15
Javascript
13
Communication
12
Tableau
12
Gcp
11
Microsoft Excel
10
THE PEOPLE BUILDING THE FIELD

Founders and leaders

291 founders and chief executives across 180 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

61 profiles with education records.

IIT Delhi
17
BITS Pilani
7
Indian School of Business
7
Stanford University
5
University of Delhi
5
IIM Calcutta
4
IIT Roorkee
4
IIM Ahmedabad
3

Prior employers

14 profiles with prior-work records.

Microsoft
4
McKinsey
2
Goldman Sachs
2
Uber
2
Bain
2
Boston Consulting Group
1
Flipkart
1

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

1,399,688 articles in the measured 12-month window.

Expand panel +
1,399,688articles in the measured year
363,432articles in 2026Q1
60.2%positive tone in the latest complete year

News volume trends

Healthtech coverage across India · articles per complete quarter

0127,620255,240382,859510,4792021Q2: 227,7252021Q22021Q3: 222,9052021Q4: 192,1692022Q1: 226,9192022Q2: 236,3122022Q22022Q3: 272,1302022Q4: 278,4432023Q1: 314,1392023Q2: 279,9712023Q22023Q3: 303,1532023Q4: 273,7762024Q1: 298,8372024Q2: 299,9732024Q22024Q3: 333,4202024Q4: 343,1372025Q1: 389,2172025Q2: 325,8972025Q22025Q3: 443,8952025Q4: 274,9952026Q1: 363,4322026Q1
View quarterly article counts
QuarterArticles
2021Q2227,725
2021Q3222,905
2021Q4192,169
2022Q1226,919
2022Q2236,312
2022Q3272,130
2022Q4278,443
2023Q1314,139
2023Q2279,971
2023Q3303,153
2023Q4273,776
2024Q1298,837
2024Q2299,973
2024Q3333,420
2024Q4343,137
2025Q1389,217
2025Q2325,897
2025Q3443,895
2025Q4274,995
2026Q1363,432

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
436,908 positive · 50,617 neutral · 255,788 negative
2022
623,235 positive · 71,739 neutral · 317,192 negative
2023
756,138 positive · 83,282 neutral · 330,012 negative
2024
818,404 positive · 122,100 neutral · 332,983 negative
2025
861,562 positive · 176,065 neutral · 394,103 negative

Leading coverage topics

Healthtech coverage across India · ranked by full-period article count.

Geopolitical Disputes And Contested Areas300,774 articles in the full recorded period
108,119 recent · 81,398 prior
International And Transnational Geographic Entities300,755 articles in the full recorded period
108,111 recent · 81,397 prior
Administrative And Political Subdivisions300,699 articles in the full recorded period
108,088 recent · 81,386 prior
International Sports Competitions110,968 articles in the full recorded period
26,956 recent · 26,689 prior
International Political Relations73,297 articles in the full recorded period
22,924 recent · 15,342 prior
Political Party Dynamics64,595 articles in the full recorded period
13,838 recent · 12,274 prior
New Product Launches And Innovations59,054 articles in the full recorded period
17,736 recent · 13,690 prior
Cricket Test Matches55,355 articles in the full recorded period
13,466 recent · 11,875 prior
Strategic Partnerships And Collaborations51,048 articles in the full recorded period
15,695 recent · 11,559 prior
Trade Policies And Agreements46,850 articles in the full recorded period
22,775 recent · 11,682 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

India comparison coverage

KeywordRecentPriorChange
tariff negotiations11,6205,680105%
bilateral trade4,6102,43789%
trade dispute mechanisms4,5112,203105%
trade barrier reduction4,4962,44084%
trade facilitation commitments4,3272,20197%
countries4,1931,860125%
free trade deals4,0782,42968%
multilateral diplomacy3,9182,72344%
diplomatic strategies3,8162,35062%
bilateral trade imbalance3,2812,04461%
odi cricket6,0369,660-38%
limited overs cricket5,7779,308-38%
odi tactics5,6288,746-36%
odi series5,2568,324-37%
odi tournaments5,0328,067-38%

Event and signal lenses

India comparison coverage

All complete annual cohorts shown
Rising

Regulatory Risk

1,870,056 classified articles

territories, disputed islands, test cricket

44.3% critical · 27.2% positive
Rising

Funding Momentum

243,523 classified articles

pre-ipo valuation, ipo prospectus, ipo pricing

49.3% critical · 46.7% positive
Rising

Growth

523,097 classified articles

gdp growth rate, economic output growth, economic growth statistics

46.9% critical · 50.7% positive

Healthtech coverage across India. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Healthtech research is working on

3,029 papers in the recorded india scope.

Expand panel +
3,029papers
53,214worldwide comparison pool
3,029India-affiliated papers

Research orientation

Promising
977
Breakthrough
819
Problem-identifying
659
Descriptive
326
Cautionary
157
Comparative
72
Critical
19

Contribution mix

Methods-led
1,235
Reviews
754
Empirical
673
Position pieces
359
Theoretical
8

Tone counts: 2,771 positive · 35 neutral · 223 negative.

Common problems researchers identify
678 papers · 22.4% of this field
  • Health care295 papers
  • Digital health225 papers
  • Public health91 papers
  • Mental health84 papers
  • Health informatics81 papers
  • Psychological intervention71 papers
  • Health administration54 papers
  • Telemedicine44 papers

Landmark: Barriers and facilitators to utilizing digital health technologies by healthcare professionals

Cautions
157 papers · 5.2% of this field
  • Health care70 papers
  • Digital health56 papers
  • Psychological intervention27 papers
  • Mental health23 papers
  • Telemedicine16 papers
  • Health informatics14 papers
  • Public health11 papers
  • Telehealth11 papers

Landmark: Digital mental health apps and the therapeutic alliance: initial review

Opportunities
1,796 papers · 59.3% of this field
  • Health care677 papers
  • Digital health297 papers
  • Wearable computer246 papers
  • Remote patient monitoring243 papers
  • Internet of Things151 papers
  • Mental health135 papers
  • Telemedicine126 papers
  • Cloud computing120 papers

Landmark: Feature selection and classification systems for chronic disease prediction: A review

Leading institutions

Public Health Foundation of India
905
Manipal Academy of Higher Education
620
Institute of Mental Health
606
Christian Medical College, Vellore
542
Vellore Institute of Technology University
521
All India Institute of Medical Sciences
465

Leading researchers

Lenny Vasanthan
537
Israel Júnior Borges do Nascimento
520
Hebatullah Mohamed Abdulazeem
520
Edson Zangiacomí Martínez
511
Miriane Lucindo Zucoloto
511
Apurvakumar Pandya
366
Pragya Lodha
366
Divya Jain
362

Highly cited breakthrough-labelled papers

  • How and under what circumstances do quality improvement collaboratives lead to better outcomes? A systematic review237 citations
  • Determinants of effective vaccine coverage in low and middle-income countries: a systematic review and interpretive synthesis165 citations
  • An IoT based Patient Health Monitoring System135 citations
  • Standard electronic health record (EHR) framework for Indian healthcare system114 citations
  • An introduction to digital determinants of health113 citations

Common problems researchers identify

2,282 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Antimicrobial Resistance and Device ChallengesCommon problems researchers identify · 01

Antimicrobial Resistance and Device Challenges

539 papers

23.6% of this theme group

Researchers highlight rising drug resistance and limitations of current medical devices in treating infectious diseases.

Disease (84) · Human health (29) · Antibiotic resistance (37) · Medical device (35)

Leishmaniasis: A multifaceted approach to diagnosis, maladies, drug repurposing and way forward

Multitargeting: An Alternative Approach to Tackle Multidrug Resistancein Tuberculosis

View research history
YearShare index
20221311.9
20231170.0
20241054.1
20251320.5
Digital Health Access GapsCommon problems researchers identify · 02

Digital Health Access Gaps

495 papers

21.7% of this theme group

Papers point to barriers and uneven adoption of digital tools across public health and care delivery.

Digital health (175) · Health care (224) · Public health (93) · Health administration (49)

The intersection of technology and mental health: enhancing access and care

Digital Healthcare and Patient Transformation: Review Research and Future Agenda

View research history
YearShare index
2022449.4
2023435.7
2024441.9
2025764.8
Precision Oncology and Genomic GapsCommon problems researchers identify · 03

Precision Oncology and Genomic Gaps

299 papers

13.1% of this theme group

Studies note difficulties in translating genomic insights into personalized cancer and ocular therapies.

Precision medicine (227) · Personalized medicine (137) · Cancer (39) · Genomics (22)

Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies

Precision medicine in cancer treatment: Revolutionizing care through proteomics, genomics, and personalized therapies

View research history
YearShare index
2022764.3
20231049.9
2024798.6
2025777.4
AI Integration and Data OverloadCommon problems researchers identify · 04

AI Integration and Data Overload

268 papers

11.7% of this theme group

Authors discuss obstacles in applying AI and big‑data analytics within Indian healthcare settings.

Health care (131) · Wearable computer (36) · Big data (33) · Applications of artificial intelligence (24)

Artificial Intelligence in Healthcare: Transforming the Future of Medicine

Artificial intelligence and machine learning in healthcare: a comprehensive review

View research history
YearShare index
202243.0
202345.3
202447.8
202586.2
Drug Discovery BottlenecksCommon problems researchers identify · 05

Drug Discovery Bottlenecks

248 papers

10.9% of this theme group

Works identify challenges in discovering and developing new drugs, especially from natural sources.

Drug discovery (213) · Drug (105) · Natural product (37) · Drug development (57)

Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective

Drug Discovery and Development Processes

View research history
YearShare index
2022154.6
2023159.2
2024166.2
2025206.1
Telemedicine Implementation BarriersCommon problems researchers identify · 06

Telemedicine Implementation Barriers

229 papers

10.0% of this theme group

Research flags technical, regulatory, and acceptance issues limiting telehealth expansion.

Telemedicine (193) · Health care (120) · Telehealth (46) · Medical emergency (22)

Telemedicine for healthcare: Capabilities, features, barriers, and applications

Exploring the potential of telemedicine for improved primary healthcare in India: a comprehensive review

View research history
YearShare index
2022215.3
2023197.2
2024209.5
2025199.0
Pandemic‑Driven Telehealth StrainCommon problems researchers identify · 07

Pandemic‑Driven Telehealth Strain

204 papers

8.9% of this theme group

Papers describe how COVID‑19 exposed weaknesses in remote care infrastructure and readiness.

Pandemic (159) · Coronavirus disease 2019 (124) · Telemedicine (110) · 2019-20 coronavirus outbreak (21)

Telehealth and the COVID-19 Pandemic: International Perspectives and a Health Systems Framework for Telehealth Implementation to Support Cri

Comprehending Telemedicine: An Online Survey amidst COVID-19 Pandemic

View research history
YearShare index
2022548.5
2023379.1
2024244.3
2025190.4

Cautions

455 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Pharmacogenomics UncertaintyCautions · 01

Pharmacogenomics Uncertainty

104 papers

22.9% of this theme group

Authors caution that personalized drug monitoring in oncology remains complex and under‑validated.

Pharmacogenomics (12) · Drug (21) · Precision medicine (16) · Cancer (10)

Targeted drug monitoring in oncology for personalized treatment with use of next generation analytics

INVESTIGATIONAL THERAPIES AND TARGETED APPROACHES IN METAPLASTIC BREAST CANCER: A SYSTEMATIC REVIEW OF EMERGING PHARMACOLOGICAL STRATEGIES

View research history
YearShare index
2022141.0
2023147.0
2024157.4
2025213.9
AI Reliability in Clinical DecisionsCautions · 02

AI Reliability in Clinical Decisions

91 papers

20.0% of this theme group

Studies warn about over‑reliance on AI without robust validation for patient assessment.

Applications of artificial intelligence (20) · Big data (15) · Precision medicine (26) · Health care (42)

Advancements in the treatment of autoimmune diseases: Integrating artificial intelligence for personalized medicine

Artificial intelligence (AI): using ai to assist in patient assessment, diagnostics, and clinical decision-making

View research history
YearShare index
202227.5
202330.3
202435.4
202589.2
Telemedicine Clinical Efficacy ConcernsCautions · 03

Telemedicine Clinical Efficacy Concerns

66 papers

14.5% of this theme group

Research questions the comparative effectiveness of remote versus in‑person care for specific conditions.

Telemedicine (54) · Health care (38) · Telerehabilitation (8) · Medical emergency (8)

Telemedicine in Geriatric Psychiatry: Relevance in India

Telemedicine Versus In-Person Visits in Postoperative Care in Orthopedic Patients: Follow-Up Study From North India

View research history
YearShare index
2022213.6
2023195.8
2024207.4
2025194.7
Digital Health Impact AmbiguityCautions · 04

Digital Health Impact Ambiguity

58 papers

12.7% of this theme group

Papers highlight mixed evidence on how digital tools affect patient outcomes and experience.

Health care (33) · Digital health (18) · Public health (10) · Health informatics (10)

Utilizing Digital Health Technologies To Improve Patient Experience And Care Quality In Global Healthcare: A Systematic Review

An impact of digital technologies on healthcare and patient outcomes: A review

View research history
YearShare index
2022453.1
2023438.9
2024445.9
2025773.9
AI Limits in Drug DevelopmentCautions · 05

AI Limits in Drug Development

48 papers

10.5% of this theme group

Authors note that AI‑driven discovery still faces practical and regulatory hurdles.

Drug discovery (35) · Drug (22) · Drug development (11) · Repurposing (8)

Exploring AI-driven approaches to drug discovery and development

The AI-Driven Future of Drug Discovery: Innovations, Applications, and Challenges

View research history
YearShare index
2022158.5
2023163.5
2024171.8
2025214.7
Mental‑Health App RisksCautions · 06

Mental‑Health App Risks

45 papers

9.9% of this theme group

Works raise concerns about efficacy, privacy, and dependency of digital mental‑health interventions.

Mental health (22) · Psychological intervention (20) · Digital health (20) · Intervention (5)

Digital wellness or digital dependency? a critical examination of mental health apps and their implications

The Role of Technology in Mental Health: Evaluating Digital Interventions for Psychological Well-being

View research history
YearShare index
2022784.7
2023800.0
2024802.5
20251143.3
Telehealth Satisfaction VariabilityCautions · 07

Telehealth Satisfaction Variability

43 papers

9.5% of this theme group

Studies reveal inconsistent patient satisfaction and adoption during and after the pandemic.

Pandemic (32) · Coronavirus disease 2019 (22) · Telemedicine (25) · Telehealth (13)

A Review of Patient Satisfaction and Experience with Telemedicine: A Virtual Solution During and Beyond COVID-19 Pandemic

International survey of audiologists during the COVID-19 pandemic: use of and attitudes to telehealth

View research history
YearShare index
2022548.5
2023379.1
2024244.3
2025190.4

Opportunities

7,409 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Natural‑Product Drug DiscoveryOpportunities · 01

Natural‑Product Drug Discovery

1,076 papers

17.9% of this theme group

Research explores plant‑derived compounds and peptides as promising sources for new therapeutics.

Drug discovery (338) · Drug (231) · Combinatorial chemistry (69) · Health benefits (48)

Fungal Endophytes as Efficient Sources of Plant-Derived Bioactive Compounds and Their Prospective Applications in Natural Product Drug Disco

Antimicrobial Peptides: The Production of Novel Peptide-Based Therapeutics in Plant Systems

View research history
YearShare index
2022164.8
2023169.5
2024181.6
2025220.1
AI‑Driven Diagnostic and Predictive ToolsOpportunities · 02

AI‑Driven Diagnostic and Predictive Tools

1,059 papers

17.6% of this theme group

Papers showcase deep‑learning models and chatbots that could enhance disease detection and personalized care.

Health care (352) · Convolutional neural network (91) · Applications of artificial intelligence (54) · Chatbot (50)

AI in Healthcare: Opportunities and Challenges for Personalized Medicine and Disease Diagnosis

AI-Driven Healthcare Solutions: Utilizing Deep Learning for Predictive Analytics and Personalized Medicine

View research history
YearShare index
202236.8
202339.0
202429.7
202547.6
Biomarker‑Based Precision OncologyOpportunities · 03

Biomarker‑Based Precision Oncology

940 papers

15.7% of this theme group

Studies identify novel biomarkers and computational methods to tailor cancer treatments.

Precision medicine (419) · Personalized medicine (304) · Cancer (216) · Biomarker (72)

Addressing Challenges and Opportunities in Precision Medicine Using Deep Learning and Personalized Cancer Treatment

Precision and personalized medicine: new way for cancer management

View research history
YearShare index
2022764.3
20231049.9
2024798.6
2025777.4
Telehealth Expansion for Chronic CareOpportunities · 04

Telehealth Expansion for Chronic Care

826 papers

13.8% of this theme group

Works highlight telemedicine’s potential to improve access, management, and outcomes for long‑term conditions.

Telemedicine (357) · Health care (305) · Telehealth (103) · Digital health (135)

Optimizing healthcare outcomes and broadening nursing capabilities in digital era: telemedicine transformative impact

Advancing Public Health: A Comprehensive Analysis of Telemedicine in Chronic Disease Management, Access Improvement, and Health Promotion Pr

View research history
YearShare index
202265.1
202364.6
202463.7
2025106.3
In‑Silico Screening for AntiviralsOpportunities · 05

In‑Silico Screening for Antivirals

773 papers

12.9% of this theme group

Research leverages virtual docking and modeling to accelerate antiviral drug identification.

Virtual screening (376) · Docking (374) · In silico (288) · Computational biology (210)

<i>In Silico</i>molecular docking and dynamic analysis of natural compounds against major non-structural proteins of SARS-COV-2

Insights into novel inhibitors intending HCMV protease a computational molecular modelling investigation for antiviral drug repurposing

View research history
YearShare index
202228.9
202330.4
202428.8
202532.8
Drug Repurposing StrategiesOpportunities · 06

Drug Repurposing Strategies

690 papers

11.5% of this theme group

Papers propose reusing existing medicines, aided by AI, to address unmet therapeutic needs.

Drug discovery (513) · Drug (300) · Drug development (107) · Drug repositioning (82)

Drug repurposing: An emerging approach to drug discovery

LEVERAGING ARTIFICIAL INTELLIGENCE IN MEDICINAL CHEMISTRY: ADVANCES IN DRUG SYNTHESIS, DEVELOPMENT AND DESIGN

View research history
YearShare index
2022158.5
2023163.5
2024171.8
2025214.7
IoT‑Enabled Remote MonitoringOpportunities · 07

IoT‑Enabled Remote Monitoring

636 papers

10.6% of this theme group

Studies demonstrate wearable and IoT platforms for continuous patient tracking and care delivery.

Remote patient monitoring (196) · Internet of Things (170) · Wearable computer (170) · Health care (244)

IoT-Driven Smart Healthcare Systems for Remote Patient Monitoring and Management

IoT Based Effective Wearable Healthcare Monitoring System For Remote Areas

View research history
YearShare index
202240.1
202342.4
202445.7
202572.4

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Promising32.3%37.8%
Breakthrough27.0%25.7%
Problem-identifying21.8%9.7%
Descriptive10.8%17.5%
Cautionary5.2%4.4%
Comparative2.4%4.0%
Critical0.6%1.0%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceSocial Connectedness, Excessive Screen Time During COVID-19 and Mental Health: A Review of Current Evidence3703.08%131 (35.4%)2.66%
Safety & misusePolitical dimensions of misinformation, trust, and vaccine confidence in a digital age110.09%7 (63.6%)0.17%
Hardware, e-waste & supply chainE-wastes Management in AI Context: The Opportunities and Challenges in Educational and Healthcare Waste – <i>A Scientifi50.04%1 (20.0%)0.01%
Energy & datacenter footprintSUSTAINABLE GREEN COMPUTING FOR MEDICAL APPLICATIONS: ADVANCING RESPONSIBLE HEALTHCARE IT40.03%3 (75.0%)0.01%
Carbon & emissions of computeFrom Opaqueness to Transparency: Sustainable AI in Diabetes Prediction10.01%0 (0.0%)0.0%
Labour & data workGIG worker protections: designing a new labour category for the digital economy10.01%1 (100.0%)0.01%
Bias & fairnessA Comprehensive Review of Bias and Fairness in Artificial Intelligence for Oral Cancer Detection10.01%1 (100.0%)0.06%
Concentration of compute powerRole of Artificial Intelligence, Big Tech and Machine Learning in Accelerating Biologics Development and Clinical Trials10.01%0 (0.0%)0.01%
Water use00.0%0 (%)0.0%

Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.

Institution and researcher rankings use citations to their covered work. Research scope: India. This may be broader than the company geography.

UNDERSTAND THE LANDSCAPE

Healthtech in Gurugram: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

KEEP EXPLORING

Put Gurugram in context

All landscapes ↗

Company ecosystem snapshot: 5 August 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon